Valuation GSK plc Xetra

Stocks

Market Closed - Xetra Other stock markets 11:35:35 2026-07-24 EDT			After hours 15:01:21
22.53 ^EUR	+1.03%		22.48	-0.20%

12:12pm	European Stocks Close Higher Friday; Eurozone Private Sector Expands in July	MT
09:38am	GSK : JP Morgan reiterates its Sell rating	ZD

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,458	58,381	59,112	54,944	73,201	76,444	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	4.43%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	91,914	88,919	85,667
Change	-	-24.65%	-1.89%	-8.24%	28.83%	4.86%	-3.26%	-3.66%
P/E	18.6x	3.93x	11.9x	21.3x	12.9x	12x	11.1x	10.8x
PBR	5.34x	5.47x	4.4x	4.02x	-	4.39x	3.67x	3.16x
PEG	-	0x	-0.2x	-0.4x	0x	1x	1.29x	5.17x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.25x	2.14x	2.08x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.71x	2.49x	2.33x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	7.84x	7.08x	6.62x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	8.96x	7.97x	7.37x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	16.1x	14.6x	13.3x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	6.2%	6.86%	7.54%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.696	0.7317	0.7632
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.65%	3.84%	4.01%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.587	1.724	1.76
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	43.9%	42.4%	43.4%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,910	35,652	36,793
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,727	12,551	12,935
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,259	11,155	11,631
Net income ¹	4,385	14,956	4,928	2,575	5,716	6,468	6,922	7,063
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	15,469	12,475	9,222
Reference price ²	20.08	14.38	14.50	13.46	18.24	19.06	19.06	19.06
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	3,982,520	-	-
Announcement Date	2/9/22	2/1/23	1/31/24	2/5/25	2/4/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	35.39x	12.58x	26.43x	0.57%	1,057B
JOHNSON & JOHNSON	27.79x	6.35x	17.58x	2.07%	624B
ABBVIE INC.	33.47x	7.59x	15.59x	2.68%	454B
ROCHE HOLDING AG	20.98x	4.63x	11.4x	2.86%	341B
NOVARTIS AG	21.62x	5.7x	13.97x	2.82%	297B
ASTRAZENECA PLC	21.08x	4.45x	12.3x	1.98%	262B
NOVO NORDISK A/S	14.13x	5.26x	10.83x	3.54%	215B
AMGEN INC.	24.37x	6.41x	11.32x	2.71%	201B
GILEAD SCIENCES, INC.	-47.14x	5.65x	31.2x	2.52%	162B
Average	16.85x	6.51x	16.74x	2.42%	401.55B
Weighted average by Cap.	24.72x	7.88x	18.52x	1.98%